Cognitive functioning in medication-free obsessive-compulsive patients treated with cognitive-behavioural therapy

Journal of Obsessive-Compulsive and Related Disorders

Volumn 2, Issue 3, 2013, Pages 241-248

  Voderholzer, Ulrich ^a,b   Schwartz, Caroline ^c   Freyer, Tobias ^a   Zurowski, Bartosz ^d   Thiel, Nicola ^a   Herbst, Nirmal ^a   Wahl, Karina ^d   Kordon, Andreas ^d   Hohagen, Fritz ^d   Kuelz, Anne Katrin ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Schoen Clinic Roseneck   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Cognitive behavioural therapy; Cognitive functions; Exposure and response prevention; Neuropsychology; Obsessive compulsive disorder; Predictors

Indexed keywords

ADULT; ARTICLE; COGNITION; COGNITIVE DEFECT; COGNITIVE THERAPY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL FUNCTION; MENTAL TEST; NEUROPSYCHOLOGICAL TEST; OBSESSIVE COMPULSIVE DISORDER; PREDICTION; PRIORITY JOURNAL; SPEECH; TEST RETEST RELIABILITY; TREATMENT OUTCOME; TREATMENT RESPONSE; YALE BROWN OBSESSIVE COMPULSIVE SCALE;

EID: 84879373680     PISSN: 22113649     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocrd.2013.03.003     Document Type: Article

References (72)

1. Abramowitz J. The psychological treatment of obsessive compulsive disorder. Canadian Journal of Psychiatry 2006, 51:407-416.
2. Andres S., Lazaro L., Salamero M., Boget T., Penades R., Castro-Fornieles J. Changes in cognitive dysfunction in children and adolescents with obsessive-compulsive disorder after treatment. Journal of Psychiatric Research 2008, 42:507-514.
3. Bandelow, B. (1997). Panik- und Agoraphobieskala. Götingen: Hogrefe.
4. Bäumler G. A series of combined weight-discrimination and size-weight illusion tests. Sportonomics 1995, 1:96-99.
5. Baxter L.R., Schwartz J.M., Bergman K.S., Szuba M.P., Guze B.H., Mazziotta J.C., et al. Caudate glucose metabolic rate changes with both drug and behaviour therapy for obsessive-compulsive disorder. Archives of General Psychiatry 1992, 49:681-689.
6. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Archives of General Psychiatry 1961, 4:561-571.
7. Beck A., Steer R.A. Beck anxiety inventory 1988, The Psychological Corporation, San Antonio, TX.
8. Binder L.M. Constructional strategies on complex figure drawings after unilateral brain damage. Journal of Clinical Neuropsychology 1982, 4:51-58.
9. Bolton D., Raven P., Madronal-Luque R., Marks I.M. Neurological and neuropsychological signs in obsessive-compulsive disorder: interaction with behavioural treatment. Behaviour Research and Therapy 2000, 38:695-708.
10. Brown T.E. Brown attention-deficit disorder scales 1996, Psychological Corporation, San Antonio.
11. Bullinger, M., & Kirchberger I. (1998). SF-36 Health Survey, German Version: Handbook. Göttingen: Hogrefe-Verlag.
12. Cavedini P., Riboldi G., D'Annucci A., Belotti P., Cisima M., Bellodi L. Decision-making heterogeneity in obsessive-compulsive disorder: Ventromedial prefrontal cortex function predicts different treatment outcomes. Neuropsychologia 2002, 40(2):205-211.
13. Chambless D.L., Caputo G.C., Bright P., Gallagher R. Assessment of fear of fear in agoraphobics: The body sensations questionnaire and the agoraphobic cognitions questionnaire. Journal of Consulting and Clinical Psychology 1984, 52:1090-1097.
14. Clark D. Cognitive-behavioural therapy for OCD 2004, Guilford Press, New York.
15. D'Alcante C., Diniz J.B., Fossaluza V., Batistuzzo M., Lopes A.C., Shavitt R.G., et al. Neuropsychological predictors of response to randomized treatment in obsessive-compulsive disorder. Progress in Neuro-Psychopharmacology 2012, 39:310-317.
16. Endicott J., Spitzer R.L., Fleiss J.L., Cohen J. The global assessment scale. Archives of General Psychiatry 1976, 33:766-771.
17. Fernandez A.L., Moroni M.A., Carranza J.M., Fabbro N., Lebowitz B.K. Reliability of the five-point test. Journal of Clinical Neuropsychology 2009, 23(3):501-509.
18. Fineberg N.A., Reghunandanan S., Brown A., Pampaloni I. Pharmacotherapy of obsessive-compulsive disorder: Evidence-based treatment and beyond. Australian and New Zealand Journal of Psychiatry 2013, Advance online publication. 10.1177/0004867412461958.
19. Fisher P.L., Wells A. Howe effective are cognitive and behavioral treatments for obsessive-compulsive disorder? A clinical significance analysis. Behaviour Research and Therapy 2005, 12:1543-1558.
20. Flessner A., Allgair A., Gracia A., Freeman J., Sapyta J., Frankling M.E., et al. The impact of neuropsychological functioning on treatment outcome in pediatric obsessive-compulsive disorder. Depress Anxiety 2010, 27:365-371.
21. Foa E.B., Huppert J.D., Leiberg S., Langner R., Kichic R., Hajcak G., et al. Obsessive-compulsive inventory: Development of a short version. Psychological Assessment 2002, 14:485-496.
22. Freedman M., Oscar-Berman M. Bilateral frontal lobe disease and selective delayed response deficits in humans. Behavioral Neuroscience 1986, 100:207-208.
23. Freyer T., Klöppel S., Tüscher O., Kordon A., Zurowski B., Kuelz A.K., et al. Frontostriatal activation in patients with obsessive-compulsive disorder before and after cognitive behavioral therapy. Psychological Medicine 2011, 41:207-216.
24. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Fleischmann R.L., Hill C.L., et al. The Yeale-Brown Obsessive Scale, 1: development, use, reliability. Archives of General Psychiatry 1989, 46:1006-1011.
25. Guy, W. (1976). ECDEU Assessment Manual for Psychopharmacology. Washington, DC: US Dept. of Health, Education and Welfare.
26. Hamilton M. A rating scale for depression. Journal of Neurology Neurosurgery & Psychiatry 1960, 23:56-62.
27. Heldt E., Manfro G., Kipper L. One-year follow-up of pharmacotherapy-resistant patients with panic disorder treated with cognitive-behaviour therapy: Outcome and predictors of remission. Behaviour Research and Therapy 2006, 44(5):657-665.
28. Herrera-Guzman I., Herrera-Abarca J.E., Gudayol-Ferré E., Herrera-Guzman D., Gomez-Carbajal L., Pena-Olvira M., et al. Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on attention and executive functions in patients with major depressive disorder. Psychiatry Research 2010, 177:323-329.
29. Horn, W. (1962). Das Leistungsprüfystem (L-P-S). The Performance-Test-System. Göttingen: Hogrefe.
30. Jacobson N.S., Truax P. Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology 1991, 59:12-19.
31. Kaijsers P.J., Hoogduin A.L., Schaap P.D.R. Predictors of treatment outcome in the behavioural treatment of obsessive-compulsive disorder. British Journal of Psychiatry 1994, 165(6):781-786.
32. Kang D.H., Kwon J.S., Kim J.J., Youn T., Park H.J., Kim M.S., et al. Brain glucose metabolic changes associated with neuropsychological improvements after 4 months of treatment in patients with obsessive-compulsive disorder. Acta Psychiatrica Scandinavica 2003, 107:291-297.
33. Kim M.S., Park S.J., Shin M.S., Kwon J.S. Neuropsychological profile in patients with obsessive-compulsive disorder over a period of 4-month treatment. Journal of Psychiatric Research 2002, 36:257-265.
34. Kuelz A., Hohagen F., Voderholzer U. Neuropsychological performance in obsessive-compulsive disorder: a critical review. Biological Psychology 2004, 65:185-236.
35. Kuelz A., Riemann D., Halsband U., Vielhaber K., Unterrainer J., Kordon A., et al. Neuropsychological impairment in OCD - improvement over the course of cognitive behavioral treatment. Journal of Clinical and Experimental Neuropsychology 2006, 28:1-15.
36. Lakatos, A., & Reinecker, H. (2007). Kognitive Verhaltenstherapie bei Zwangsstörungen. Ein Therapiemanual. (3., überarbeitete. Aufl.). Göttingen: Hogrefe.
37. Liberman J.N., Stewart W., Seines O., Gordon B. Rater agreement for the Rey-Osterrieth complex figure test. Journal of Clinical Psychology 1994, 50(4):615-624.
38. Markarian Y., Larson M., Aldea M., Baldwin S., Good D., Berkeljon A., et al. Multiple pathways to functional impairment in obsessive-compulsive disorder. Clinical Psychology Review 2010, 30(1):78-88.
39. Mataix-Cols D., Marks I.M., Greist J.H. Obsessive-compulsive symptom dimensions as predictors of compliance with response to behaviour therapy: Results from a controlled trial. Psychotherapy and Psychosomatics 2002, 71(5):255-262.
40. Meyers, J. E., & Meyers, K. R. (1995). Rey complex figures test and recognition trial: professional manual. Odessa. Psychological Assessment Ressources.
41. Miller E.K., Cohen J.D. An integrative theory of prefrontal cortex function. Annual Review of Neuroscience 2001, 24:167-202.
42. Moritz S., Kloss M., Jacobsen D., Fricke S., Cuttler C., Brassen S., et al. Neurocognitive impairment does not predict treatment outcome in obsessive-compulsive disorder. Behaviour Research and Therapy 2005, 43:811-819.
43. Moritz S., Kloss M., Katenkamp B., Birkner C., Hand I. Neurocognitive functioning in OCD before and after treatment. CNS Spectrums 1999, 4:21-22.
44. Nabeyama M., Nakagawa A., Yoshiura T., Nakao T., Nakatani E., Togao O., et al. Functional MRI study of brain activation alterations in patients with obsessive-compulsive disorder after symptom improvement. Psychiatry Research 2008, 163:236-247.
45. Nakao T., Nakagawa A., Yoshiura T., Nakatani E., Nabeyama M., Yoshizato C., et al. Brain activation of patients with obsessive-compulsive disorder during neuropsychological and symptom provocation tasks before and after symptom improvement: A functional magnetic resonance imaging study. Biological Psychiatry 2005, 57:901-910.
46. Nakatani E., Nakagawa A., Ohara Y., Goto S., Uozumi N., Ivakiri M., et al. Effects of behaviour therapy on regional cerebral blood flow in obsessive-compulsive disorder. Psychiatry Research 2003, 124:113-120.
47. Nielen M.M., Den Boer J.A. Neuropsychological performance of OCD patients before and after treatment with fluoxetine: Evidence for persistent cognitive deficits. Psychological Medicine 2003, 33:917-925.
48. Cognitive assessment of obsessive compulsive disorder. Behaviour Research and Therapy 1997, 35:667-681. Obsessive-Compulsive Cognitions Working Group (OCCWG).
49. Development and initial validation of the obsessive beliefs questionnaire and the interpretation of intrusions inventory. Behaviour Research and Therapy 2001, 39:987-1006. Obsessive Compulsive Cognitions Working Group (OCCWG).
50. Overton S., Menzies R. Cognitive change during treatment of compulsive checking. Behaviour Change 2005, 22(3):172-184.
51. Rampacher F., Lennertz L., Vogeley A., Schulze-Rauschenbach S., Kathmann N., Falkai P., et al. Evidence for specific cognitive deficits in visual information processing in patients with OCD compared to patients with unipolar depression. Progress in Neuro-Psychopharmacology 2010, 34(6):984-991.
52. Raven J. Manual for Raven's progressive matrices and Mill Hill vocabulary scales 1991, Oxford Psychologists Press, Oxford, Research supplement no. 1.
53. Regard M., Strauss E., Knapp P. Children's production on verbal and nonverbal fluency tasks. Perceptual Motor Skill 1985, 55:839-844.
54. Reitan R.M. Validity of the trailmaking test as an indication of organic brain damage. Perceptual Motor Skill 1958, 8:271-276.
55. Retz-Junginger R., Retz W., Blocher D., Weijers H.-G., Trott G.-E., Wender P.H., et al. Wender Utah rating scale (WURS-k). Nervenarzt 2002, 73:830-838.
56. Rufer M., Fricke S., Moritz S., Kloss M., Hand I. Symptom dimensions in obsessive-compulsive disorder: prediction of cognitive-behaviour therapy outcome. Acta Psychiatrica Scandinavica 2006, 113:440-446.
57. Salkovskis P.M. Obsessional-compulsive problems: A cognitive-behavioural analysis. Behaviour Research and Therapy 1985, 23:571-583.
58. Savage C.R., Deckersbach T., Wilhelm S., Rauch S.L., Baer L., Reid T., et al. Strategic processing and episodic memory impairment in obsessive compulsive disorder. Neuropsychology 2000, 14:141-151.
59. Saxena S., Gorbis E., O'Neill J., Baker S.K., Mandelkern M.A., Maidment K.M., et al. Rapid effects of brief intensive cognitive-behavioral therapy on brain glucose metabolism in obsessive-compulsive disorder. Molecular Psychiatry 2009, 14(2):197-205.
60. Schwartz J.M., Stoessel P.W., Baxter L.R., Martin K.M., Phelps M.E. Systematic changes in cerebral glucose metabolic rate after successful behaviour modification treatment of obsessive-compulsive disorder. Archives of General Psychiatry 1996, 53:109-113.
61. Shavitt R.G., Belotto C., Curi M., Hounie A.G., Rosario-Campos M.C., Diniz J.B., et al. Clinical features associated with treatment response in obsessive compulsive disorder. Comprehensive Psychiatry 2006, 47:276-281.
62. Shin M.S., Park S.J., Kim M.S., Lee Y.H., Ha T.H., Kwon J.S. Deficits of or-ganizational strategy and visual memory in obsessive-compulsive disorder. Neuropsychology 2004, 18(4):665-672.
63. Sieg J., Leplow B., Hand I. Neuropsychologische Minderleistung und Therapieerfolg bei der Zwangsstörung. Verhaltenstherapie 1999, 9:7-14.
64. Soref A., Dar R., Argov G., Meiran N. Obsessive-compulsive tendencies are associated with a focused information processing strategy. Behaviour Research and Therapy 2008, 46:1295-1299.
65. Spreen O., Strauss E. A compendium of neuropsychological tests 1991, Oxford university press, New York.
66. Stevens J.P. Applied multivariate statistics for the social sciences 2002, Psychology Press, Washington, DC. 4th ed.
67. Storch E.A., Lewin A.B., Farrell L., Aldea M.A., Reid J., Geffken G.R., et al. Does cognitive-behavioral therapy response among adults with obsessive-compulsive disorder differ as a function of certain comorbidities?. Journal of Anxiety Disorders 2010, 24:547-552.
68. Thienemann M., Koran L.M. Do soft signs predict treatment outcome in obsessive-compulsive disorder?. Journal of Neuropsychiatry & Clinical Neurosciences 1995, 7:218-222.
69. Tucha L., Aschenbrenner S., Koerts J., Lange K.W. The five-point test: Reliability, validity and normative data for children and adults. PLoS One 2012, 7:9.
70. Vandborg S.K., Hartmann T.B., Bennedsen B.E., Pedersen A.D., Eskildsen A., Videbech P.B., et al. Do cognitive functions in obsessive-compulsive disorder change after treatment? A systematic review and a double case report. Nordic Journal of Psychiatry 2012, 66(1):60-67. 10.3109/08039488.2011.626869.
71. Weismann, A. N., & Beck, A. T. (1979) The dysfunctional attitude scale: a validation study. Thesis, University: Philadelphia.
72. Wittchen, H. U., Zaudig, M., & Fydrich, T. (1997). Strukturiertes Klinisches Interview für DSM IV. Achse I und II. Göttingen: Hogrefe.